Revance Therapeutics, Inc. (RVNC): Price and Financial Metrics

Revance Therapeutics, Inc. (RVNC): $2.97

0.06 (-1.98%)

POWR Rating

Component Grades

Momentum

D

Stability

F

Sentiment

Quality

C

Add RVNC to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#137 of 356

in industry

RVNC Price/Volume Stats

Current price $2.97 52-week high $29.44
Prev. close $3.03 52-week low $2.57
Day low $2.96 Volume 781,791
Day high $3.15 Avg. volume 1,886,203
50-day MA $3.50 Dividend yield N/A
200-day MA $7.08 Market Cap 310.21M

RVNC Stock Price Chart Interactive Chart >


Revance Therapeutics, Inc. (RVNC) Company Bio


Revance Therapeutics is a specialty biopharmaceutical company focused on the development, manufacturing and commercialization of novel botulinum toxin products for multiple aesthetic and therapeutic indications. The company was founded in 1999 and is based in Newark, California.


RVNC Latest News Stream


Event/Time News Detail
Loading, please wait...

RVNC Latest Social Stream


Loading social stream, please wait...

View Full RVNC Social Stream

Latest RVNC News From Around the Web

Below are the latest news stories about REVANCE THERAPEUTICS INC that investors may wish to consider to help them evaluate RVNC as an investment opportunity.

Analysts Just Slashed Their Revance Therapeutics, Inc. (NASDAQ:RVNC) EPS Numbers

One thing we could say about the analysts on Revance Therapeutics, Inc. ( NASDAQ:RVNC ) - they aren't optimistic...

Yahoo | November 10, 2023

Revance Therapeutics, Inc. (NASDAQ:RVNC) Q3 2023 Earnings Call Transcript

Revance Therapeutics, Inc. (NASDAQ:RVNC) Q3 2023 Earnings Call Transcript November 8, 2023 Revance Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.63 EPS, expectations were $-1.1. Operator: Welcome to the Revance Therapeutics Third Quarter 2023 Financial Results and Corporate Update Conference Call. At this time, all participants are in a listen-only mode. Following management’s […]

Yahoo | November 10, 2023

Q3 2023 Revance Therapeutics Inc Earnings Call

Q3 2023 Revance Therapeutics Inc Earnings Call

Yahoo | November 9, 2023

Revance Therapeutics, Inc. (RVNC) Reports Q3 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Revance Therapeutics, Inc. (RVNC) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Yahoo | November 9, 2023

Revance Reports Third Quarter 2023 Financial Results, Provides Corporate Update

NASHVILLE, November 08, 2023--Revance Reports Third Quarter 2023 Financial Results, Provides Corporate Update

Yahoo | November 8, 2023

Read More 'RVNC' Stories Here

RVNC Price Returns

1-mo -14.66%
3-mo -44.02%
6-mo -63.24%
1-year -89.56%
3-year -90.10%
5-year -72.65%
YTD -66.21%
2023 -52.38%
2022 13.11%
2021 -42.41%
2020 74.61%
2019 -19.37%

Continue Researching RVNC

Here are a few links from around the web to help you further your research on Revance Therapeutics Inc's stock as an investment opportunity:

Revance Therapeutics Inc (RVNC) Stock Price | Nasdaq
Revance Therapeutics Inc (RVNC) Stock Quote, History and News - Yahoo Finance
Revance Therapeutics Inc (RVNC) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!